CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents, $1,716 reserved at March 31, 2014	$ 5,490	$ 6,258
Other current assets	235	233
Total current assets	5,725	6,491
Patent license rights, net	784	823
Furniture and equipment, net	2	3
Total assets	6,511	7,317
Current liabilities
Accounts payable	253	88
Other accrued liabilities	35	12
Total current liabilities	288	100
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2014 and 2013 issued and outstanding	20	20
Additional paid-in capital	189,243	189,215
Accumulated deficit ($155,278 at March 31, 2014 and $154,256 at December 31, 2013, accumulated during development stage period)	(183,040)	(182,018)
Total Capstone Therapeutics Corp. stockholders' equity	6,223	7,217
Noncontrolling interest	0	0
Total equity	6,223	7,217
Total liabilities and equity	$ 6,511	$ 7,317